ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Researchers at Tufts University report that silk can keep vaccines from degrading without refrigeration (Proc. Natl. Acad. Sci. USA, DOI: 10.1073/pnas.1206210109). The finding could help vaccine treatments reach more people in the developing world, where refrigeration is scarce and vaccines often heat up and lose potency before they can be administered. David L. Kaplan and colleagues dissolved silk protein in a salt solution; mixed it with measles, mumps, and rubella vaccine; and then dried the mixture into films. In the silk film, the vaccine was effective for more than six months at temperatures of up to 45 ºC, whereas the dried vaccine alone lost nearly all potency. The researchers propose that silk protein traps the vaccine’s viral particles in spaces between its β-sheets, holding the viral proteins in their native, folded state and preventing denaturation. Silk’s structure also excludes some water, enhancing its preservative qualities. The low toxicity and price of silk make it a good candidate for application, says Randolph V. Lewis, a silk protein expert at Utah State University. “It has huge potential in the human health area,” he says.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X